{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:09:34Z","timestamp":1789261774207,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"DOI":"10.1007\/s00253-026-13977-w","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:45:27Z","timestamp":1789217127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disulfiram reverses fluconazole-resistance mediated by Cdr1 in\u00a0Candida albicans and interferes with biofilm formation"],"prefix":"10.1007","volume":"110","author":[{"given":"Ahmed","family":"Rezk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba S.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin M.","family":"Elfeky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"El-Mowafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"5","key":"13977_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050884","volume":"12","author":"A Carmo","year":"2023","unstructured":"Carmo A, Rocha M, Pereirinha P, Tom\u00e9 R, Costa E (2023) Antifungals: from pharmacokinetics to clinical practice. Antibiotics (Basel) 12(5):884. https:\/\/doi.org\/10.3390\/antibiotics12050884","journal-title":"Antibiotics (Basel)"},{"issue":"18","key":"13977_CR2","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1039\/C9CC09074F","volume":"56","author":"C Chen","year":"2020","unstructured":"Chen C, Yang K-W, Wu L-Y, Li J-Q, Sun L-Y (2020) Disulfiram as a potent metallo-\u03b2-lactamase inhibitor with dual functional mechanisms. Chem Commun (Camb) 56(18):2755\u20132758. https:\/\/doi.org\/10.1039\/C9CC09074F","journal-title":"Chem Commun (Camb)"},{"key":"13977_CR3","unstructured":"CLSI-M27-A4: Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-fourth edition. Clinical and Laboratory Standard Institute, Document M27-A4 (2017). Wayne, PA. https:\/\/clsi.org\/shop\/standards\/m27\/"},{"key":"13977_CR4","unstructured":"CLSI-M44-A3: Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. Third edition. Clinical and Laboratory Standard Institute guideline M44-A3 (2018). Wayne, PA. https:\/\/clsi.org\/shop\/standards\/m44\/"},{"issue":"3","key":"13977_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/2211352520666220104104747","volume":"20","author":"MM Custodio","year":"2022","unstructured":"Custodio MM, Sparks J, Long TE (2022) Disulfiram: a repurposed drug in preclinical and clinical development for the treatment of infectious diseases. Anti-Infect Agents 20(3):34\u201345. https:\/\/doi.org\/10.2174\/2211352520666220104104747","journal-title":"Anti-Infect Agents"},{"issue":"22","key":"13977_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells12222655","volume":"12","author":"KM Czajka","year":"2023","unstructured":"Czajka KM, Venkataraman K, Brabant-Kirwan D, Santi SA, Verschoor C, Appanna VD, Singh R, Saunders DP, Tharmalingam S (2023) Molecular mechanisms associated with antifungal resistance in pathogenic Candida species. Cells 12(22):2655. https:\/\/doi.org\/10.3390\/cells12222655","journal-title":"Cells"},{"issue":"1","key":"13977_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61813-w","volume":"14","author":"AM Dawoud","year":"2024","unstructured":"Dawoud AM, Saied SA, Torayah MM, Ramadan AE, Elaskary SA (2024) Antifungal susceptibility and virulence determinants profile of Candida species isolated from patients with candidemia. Sci Rep 14(1):11597. https:\/\/doi.org\/10.1038\/s41598-024-61813-w","journal-title":"Sci Rep"},{"issue":"11","key":"13977_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/md22110502","volume":"22","author":"LT Domingos","year":"2024","unstructured":"Domingos LT, de Moraes DC, Santos MF, Curvelo JA, Bayona-Pacheco B, Marquez EA, Martinez AW, Berlinck RG, Ferreira-Pereira A (2024) Batzelladine D, a marine natural product, reverses the fluconazole resistance phenotype mediated by transmembrane transporters in Candida albicans and interferes with its biofilm: an in Vitro and In Silico Study. Mar Drugs 22(11):502. https:\/\/doi.org\/10.3390\/md22110502","journal-title":"Mar Drugs"},{"issue":"1","key":"13977_CR9","doi-asserted-by":"publisher","DOI":"10.18502\/cmm.7.1.6181","volume":"7","author":"AM El-Ganiny","year":"2021","unstructured":"El-Ganiny AM, Yossef NE, Kamel HA (2021) Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt. Curr Med Mycol 7(1):31. https:\/\/doi.org\/10.18502\/cmm.7.1.6181","journal-title":"Curr Med Mycol"},{"issue":"3","key":"13977_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jsps.2022.01.011","volume":"30","author":"AM El-Ganiny","year":"2022","unstructured":"El-Ganiny AM, Kamel HA, Yossef NE, Mansour B, El-Baz AM (2022) Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates. Saudi Pharm J 30(3):245\u2013255. https:\/\/doi.org\/10.1016\/j.jsps.2022.01.011","journal-title":"Saudi Pharm J"},{"key":"13977_CR11","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.2147\/idr.S420580","volume":"16","author":"MA Gerges","year":"2023","unstructured":"Gerges MA, Fahmy YA, Hosny T, Gandor NH, Mohammed SY, Mohamed TMA, Abdelmoteleb NEM, Esmaeel NE (2023) Biofilm formation and aspartyl proteinase activity and their association with azole resistance among Candida albicans causing vulvovaginal candidiasis, Egypt. Infect Drug Resist 16:5283\u20135293. https:\/\/doi.org\/10.2147\/idr.S420580","journal-title":"Infect Drug Resist"},{"issue":"11","key":"13977_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nchembio.1911","volume":"11","author":"PR Gonzales","year":"2015","unstructured":"Gonzales PR, Pesesky MW, Bouley R, Ballard A, Biddy BA, Suckow MA, Wolter WR, Schroeder VA, Burnham C-AD, Mobashery S (2015) Synergistic, collaterally sensitive \u03b2-lactam combinations suppress resistance in MRSA. Nat Chem Biol 11(11):855\u2013861. https:\/\/doi.org\/10.1038\/nchembio.1911","journal-title":"Nat Chem Biol"},{"issue":"5","key":"13977_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jiac.2020.12.012","volume":"27","author":"W Hao","year":"2021","unstructured":"Hao W, Qiao D, Han Y, Du N, Li X, Fan Y, Ge X, Zhang H (2021) Identification of disulfiram as a potential antifungal drug by screening small molecular libraries. J Infect Chemother 27(5):696\u2013701. https:\/\/doi.org\/10.1016\/j.jiac.2020.12.012","journal-title":"J Infect Chemother"},{"issue":"1","key":"13977_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/imm.13255","volume":"162","author":"J Ho","year":"2021","unstructured":"Ho J, Camilli G, Griffiths JS, Richardson JP, Kichik N, Naglik JR (2021) Candida albicans and candidalysin in inflammatory disorders and cancer. Immunology 162(1):11\u201316. https:\/\/doi.org\/10.1111\/imm.13255","journal-title":"Immunology"},{"issue":"12","key":"13977_CR15","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.4155\/fmc-2016-0050","volume":"8","author":"AR Holmes","year":"2016","unstructured":"Holmes AR, Cardno TS, Strouse JJ, Ivnitski-Steele I, Keniya MV, Lackovic K, Monk BC, Sklar LA, Cannon RD (2016) Targeting efflux pumps to overcome antifungal drug resistance. Future Med Chem 8(12):1485\u20131501. https:\/\/doi.org\/10.4155\/fmc-2016-0050","journal-title":"Future Med Chem"},{"issue":"3","key":"13977_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3314\/jjmm.48.109","volume":"48","author":"S Khan","year":"2007","unstructured":"Khan S, Singhal S, Mathur T, Upadhyay DJ, Rattan A (2007) Antifungal potential of disulfiram. Nippon Ishinkin Gakkai Zasshi 48(3):109\u2013113. https:\/\/doi.org\/10.3314\/jjmm.48.109","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"key":"13977_CR17","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S299177","author":"T Kobatake","year":"2021","unstructured":"Kobatake T, Ogino K, Sakae H, Gotoh K, Watanabe A, Matsushita O, Okada H, Yokota K (2021) Antibacterial effects of disulfiram in Helicobacter pylori. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S299177","journal-title":"Infect Drug Resist"},{"issue":"3","key":"13977_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/antibiotics12030524","volume":"12","author":"J Lanz","year":"2023","unstructured":"Lanz J, Biniaz-Harris N, Kuvaldina M, Jain S, Lewis K, Fallon BA (2023) Disulfiram: mechanisms, applications, and challenges. Antibiotics (Basel) 12(3):524. https:\/\/doi.org\/10.3390\/antibiotics12030524","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"13977_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nsmb.3216","volume":"23","author":"KP Locher","year":"2016","unstructured":"Locher KP (2016) Mechanistic diversity in ATP-binding cassette (ABC) transporters. Nat Struct Mol Biol 23(6):487\u2013493. https:\/\/doi.org\/10.1038\/nsmb.3216","journal-title":"Nat Struct Mol Biol"},{"key":"13977_CR20","doi-asserted-by":"crossref","unstructured":"Long TE (2017) Repurposing thiram and disulfiram as antibacterial agents for multidrug-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 61(9).\u00a0https:\/\/doi.org\/10.1128\/aac.00898\u201317","DOI":"10.1128\/AAC.00898-17"},{"issue":"1","key":"13977_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03515-x","volume":"24","author":"AF Makled","year":"2024","unstructured":"Makled AF, Ali SAM, Labeeb AZ, Salman SS, Shebl DZM, Hegazy SG, Sabal MS (2024) Characterization of Candida species isolated from clinical specimens: insights into virulence traits, antifungal resistance and molecular profiles. BMC Microbiol 24(1):388. https:\/\/doi.org\/10.1186\/s12866-024-03515-x","journal-title":"BMC Microbiol"},{"issue":"2","key":"13977_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1590\/S1517-83822010000200004","volume":"41","author":"SA Marinho","year":"2010","unstructured":"Marinho SA, Teixeira AB, Santos OS, Cazanova RF, Ferreira CA, Cherubini K, de Oliveira SD (2010) Identification of Candida spp. by phenotypic tests and PCR. Braz J Microbiol 41(2):286\u2013294. https:\/\/doi.org\/10.1590\/S1517-83822010000200004","journal-title":"Braz J Microbiol"},{"issue":"12","key":"13977_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13121174","volume":"13","author":"AGG Mendes","year":"2024","unstructured":"Mendes AGG, Campos CDL, Pereira-Filho JL, Pereira APA, Reis GSA, Ara\u00fajo \u00c1WdMS, Monteiro PdM, Vidal FCB, Monteiro SG, da Silva Figueiredo IF (2024) Ellagic acid potentiates the inhibitory effects of fluconazole against Candida albicans. Antibiotics (Basel) 13(12):1174. https:\/\/doi.org\/10.3390\/antibiotics13121174","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"13977_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"X-Y Meng","year":"2011","unstructured":"Meng X-Y, Zhang H-X, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug des 7(2):146\u2013157. https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug des"},{"issue":"12","key":"13977_CR25","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1128\/aac.45.12.3366-3374.2001","volume":"45","author":"K Nakamura","year":"2001","unstructured":"Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD (2001) Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob Agents Chemother 45(12):3366\u20133374. https:\/\/doi.org\/10.1128\/aac.45.12.3366-3374.2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"13977_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.00078-19","volume":"63","author":"AT Nishimoto","year":"2019","unstructured":"Nishimoto AT, Zhang Q, Hazlett B, Morschh\u00e4user J, Rogers PD (2019) Contribution of clinically derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and Cdr1 expression in Candida albicans. Antimicrob Agents Chemother 63(5):10\u2013128. https:\/\/doi.org\/10.1128\/aac.00078-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"13977_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2024.101478","volume":"34","author":"S Norozipor","year":"2024","unstructured":"Norozipor S, Bamorovat M, Ayatollahi Mosavi SA, Salarkia E, Hadizadeh S, Sharifi F, Karamoozian A, Ranjbar M, Agha Kuchak Afshari S (2024) Synergistic activity of crocin and crocin loaded in niosomes alone and in combination with fluconazole against Candida albicans isolates: in vitro and in silico study. J Mycol Med 34(2):101478. https:\/\/doi.org\/10.1016\/j.mycmed.2024.101478","journal-title":"J Mycol Med"},{"issue":"4","key":"13977_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1\u2013e50. https:\/\/doi.org\/10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13977_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52107-w","volume":"15","author":"Y Peng","year":"2024","unstructured":"Peng Y, Lu Y, Sun H, Ma J, Li X, Han X, Fang Z, Tan J, Qiu Y, Qu T (2024) Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms. Nat Commun 15(1):7722. https:\/\/doi.org\/10.1038\/s41467-024-52107-w","journal-title":"Nat Commun"},{"issue":"4","key":"13977_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1128\/aac.35.4.785","volume":"35","author":"M Phillips","year":"1991","unstructured":"Phillips M, Malloy G, Nedunchezian D, Lukrec A, Howard R (1991) Disulfiram inhibits the in vitro growth of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 35(4):785\u2013787. https:\/\/doi.org\/10.1128\/aac.35.4.785","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"13977_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/13693780601059936","volume":"45","author":"DH Pincus","year":"2007","unstructured":"Pincus DH, Orenga S, Chatellier S (2007) Yeast identification-past, present, and future methods. Med Mycol 45(2):97\u2013121. https:\/\/doi.org\/10.1080\/13693780601059936","journal-title":"Med Mycol"},{"key":"13977_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fphar.2014.00202","volume":"5","author":"R Prasad","year":"2014","unstructured":"Prasad R, Rawal MK (2014) Efflux pump proteins in antifungal resistance. Front Pharmacol 5:202. https:\/\/doi.org\/10.3389\/fphar.2014.00202","journal-title":"Front Pharmacol"},{"issue":"12","key":"13977_CR33","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1128\/ec.00137-15","volume":"14","author":"R Prasad","year":"2015","unstructured":"Prasad R, Banerjee A, Khandelwal NK, Dhamgaye S (2015) The ABCs of Candida albicans multidrug transporter Cdr1. Eukaryot Cell 14(12):1154\u20131164. https:\/\/doi.org\/10.1128\/ec.00137-15","journal-title":"Eukaryot Cell"},{"issue":"1","key":"13977_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep27132","volume":"6","author":"MK Rawal","year":"2016","unstructured":"Rawal MK, Banerjee A, Shah AH, Khan MF, Sen S, Saxena AK, Monk BC, Cannon RD, Bhatnagar R, Mondal AK (2016) Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric. Sci Rep 6(1):27132. https:\/\/doi.org\/10.1038\/srep27132","journal-title":"Sci Rep"},{"key":"13977_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020461","author":"J Roana","year":"2021","unstructured":"Roana J, Mandras N, Scalas D, Campagna P, Tullio V (2021) Antifungal activity of Melaleuca alternifolia essential oil (TTO) and its synergy with itraconazole or ketoconazole against Trichophyton rubrum. Molecules. https:\/\/doi.org\/10.3390\/molecules26020461","journal-title":"Molecules"},{"issue":"4","key":"13977_CR36","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1128\/aac.47.4.1220-1227.2003","volume":"47","author":"PD Rogers","year":"2003","unstructured":"Rogers PD, Barker KS (2003) Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother 47(4):1220\u20131227. https:\/\/doi.org\/10.1128\/aac.47.4.1220-1227.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"13977_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugalcdep.2013.12.007","volume":"136","author":"RS Schottenfeld","year":"2014","unstructured":"Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR (2014) Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment. Drug Alcohol Depend 136:36\u201342. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.12.007","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"13977_CR38","doi-asserted-by":"publisher","first-page":"DC20","DOI":"10.7860\/JCDR\/2015\/10094.5494","volume":"9","author":"M Sharma","year":"2015","unstructured":"Sharma M, Biswas D, Kotwal A, Thakuria B, Kakati B, Chauhan BS, Patras A (2015) Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida. Journal of clinical and diagnostic research\u202f: JCDR 9(1):DC20. https:\/\/doi.org\/10.7860\/JCDR\/2015\/10094.5494","journal-title":"Journal of clinical and diagnostic research : JCDR"},{"issue":"3","key":"13977_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00203-023-03824-1","volume":"206","author":"K Sharma","year":"2024","unstructured":"Sharma K, Parmanu PK, Sharma M (2024) Mechanisms of antifungal resistance and developments in alternative strategies to combat Candida albicans infection. Arch Microbiol 206(3):95. https:\/\/doi.org\/10.1007\/s00203-023-03824-1","journal-title":"Arch Microbiol"},{"issue":"2","key":"13977_CR40","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bbrc.2004.07.151","volume":"322","author":"S Shukla","year":"2004","unstructured":"Shukla S, Sauna ZE, Prasad R, Ambudkar SV (2004) Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans. Biochem Biophys Res Commun 322(2):520\u2013525. https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.151","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"13977_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00181-23","volume":"67","author":"JD Sobel","year":"2023","unstructured":"Sobel JD (2023) Resistance to fluconazole of Candida albicans in vaginal isolates: a 10-year study in a clinical referral center. Antimicrob Agents Chemother 67(5):e00181\u201323. https:\/\/doi.org\/10.1128\/aac.00181-23","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"13977_CR42","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.scib.2020.12.035","volume":"66","author":"Y Tong","year":"2021","unstructured":"Tong Y, Zhang J, Sun N, Wang XM, Wei Q, Zhang Y, Huang R, Pu Y, Dai H, Ren B, Pei G, Song F, Zhu G, Wang X, Xia X, Chen X, Jiang L, Wang S, Ouyang L, Xie N, Zhang B, Jiang Y, Liu X, Calderone R, Bai F, Zhang L, Alterovitz G (2021) Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p. Sci Bull (Beijing) 66(18):1895\u20131905. https:\/\/doi.org\/10.1016\/j.scib.2020.12.035","journal-title":"Sci Bull (Beijing)"},{"issue":"30","key":"13977_CR43","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.2174\/0929867324666170523102244","volume":"24","author":"V-K Tran-Nguyen","year":"2017","unstructured":"Tran-Nguyen V-K, Prasad R, Falson P, Boumendjel A (2017) Modulators of the efflux pump Cdr1p of Candida albicans: mechanisms of action and chemical features. Curr Med Chem 24(30):3242\u20133253. https:\/\/doi.org\/10.2174\/0929867324666170523102244","journal-title":"Curr Med Chem"},{"issue":"1","key":"13977_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12866-024-03334-0","volume":"24","author":"S Wu","year":"2024","unstructured":"Wu S, Jia W, Lu Y, Jiang H, Huang C, Tang S, Du L (2024) Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans. BMC Microbiol 24(1):196. https:\/\/doi.org\/10.1186\/s12866-024-03334-0","journal-title":"BMC Microbiol"},{"issue":"5","key":"13977_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00155-25","volume":"10","author":"MC Yang","year":"2025","unstructured":"Yang MC, Huang WL, Chen HY, Lin SH, Chang YS, Tseng KY, Lo HJ, Wang IC, Lin CJ, Lan CY (2025) Deletion of RAP1 affects iron homeostasis, azole resistance, and virulence in Candida albicans. mSphere 10(5):e0015525. https:\/\/doi.org\/10.1128\/msphere.00155-25","journal-title":"mSphere"},{"issue":"2","key":"13977_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1248\/bpb.b13-00734","volume":"37","author":"SL Zhu","year":"2014","unstructured":"Zhu SL, Yan L, Zhang YX, Jiang ZH, Gao PH, Qiu Y, Wang L, Zhao MZ, Cai Z, Tian SJ, Zang CX (2014) Berberine inhibits fluphenazine-induced up-regulation of Cdr1 in Candida albicans. Biol Pharm Bull 37(2):268\u2013273. https:\/\/doi.org\/10.1248\/bpb.b13-00734","journal-title":"Biol Pharm Bull"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-026-13977-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:02:34Z","timestamp":1789261354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-026-13977-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13977"],"URL":"https:\/\/doi.org\/10.1007\/s00253-026-13977-w","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Ethics Committee of the Faculty of Pharmacy, Mansoura University, Egypt (Code number: 2022\u201355). All procedures performed in the study involving human participants were in accordance with the 1964 Helsinki Declaration and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"269"}}